These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 203395)

  • 21. 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.
    Havsteen H; Sörenson S; Rørth M; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1981; 65(1-2):123-5. PubMed ID: 6261945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
    Reck M; Haering B; Koschel G; Kaukel E; von Pawel J; Gatzemeier U
    Pneumologie; 1998 Oct; 52(10):570-3. PubMed ID: 9847635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
    Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD; Stroup SL; Greco FA
    Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptozotocin: an inactive agent in small cell carcinoma.
    Maurer LH; Weiss RB; Aisner J
    Cancer Clin Trials; 1979; 2(1):59-61. PubMed ID: 229984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
    Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
    [No Abstract]   [Full Text] [Related]  

  • 28. Complications of treatment of small cell carcinoma of the lung.
    Abeloff MD; Klastersky J; Drings PD; Eagan RT; Greco FA; Holsti L; Mattson K; Postmus PE
    Cancer Treat Rep; 1983 Jan; 67(1):21-6. PubMed ID: 6311410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
    Tempero M; Kessinger A; Lemon HM
    Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY; Witte RS; Tormey DC; Ramirez G
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
    Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E
    Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of procarbazine in small cell carcinoma of the lung.
    Pedersen AG; Sörenson S; Aabo K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):273-5. PubMed ID: 6275988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
    Creech RH; Stanley K; Vogl SE; Ettinger DS; Bonomi PD; Salazar O
    Cancer Treat Rep; 1982 Jun; 66(6):1417-9. PubMed ID: 6282460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of two combination chemotherapies for the treatment of small cell carcinoma of the lung.
    Kutsuzawa T; Hayashi Y; Kurata T; Kobayashi R; Kondo T; Sonoda Y; Takasaki Y; Shioya S; Yamauchi T; Tamaya S
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):363-9. PubMed ID: 6100629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined chemotherapy and radiotherapy of small cell carcinoma of the lung].
    Arjane G; Guay JP
    Union Med Can; 1981 Apr; 110(4):358-60. PubMed ID: 6264654
    [No Abstract]   [Full Text] [Related]  

  • 39. Laetrile 'case histories': a review and critique.
    Yarbro JW
    Mo Med; 1979 Apr; 76(4):195-202, 206. PubMed ID: 431517
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinicopathological study of the paraneoplastic neuromuscular syndromes associated with lung cancer.
    Gomm SA; Thatcher N; Barber PV; Cumming WJ
    Q J Med; 1990 Jun; 75(278):577-95. PubMed ID: 2171009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.